Medium materiality6/10
Definium Therapeutics price target raised to $78 from $64 at Canaccord
Why it may matterVerify against the original reporting
Bullish despite recent price move; upside implied by higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity raises DFTX target to $78; current price is $40.25; price change since signal is -6.87.
- Target: $78
- Posted price: $40.25
- Analyst firm: Canaccord Genuity
- Price change since signal: -6.87
Key facts
- 01
Target: $78
- 02
Posted price: $40.25
- 03
Analyst firm: Canaccord Genuity
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.